• Mashup Score: 0

    Verve Therapeutics is considering a half-dozen candidate genes that could be edited with the CRISPR technique in order to sharply reduce a patient’s levels of cholesterol or triglycerides.

    Tweet Tweets with this article
    • By the way, severity & morbidity of familial hypercholesterolemia (both HoFH & HeFH) under-appreciated 👇story of Avery Watts LDL-C in 800s Heart attack by age 12 Rx with a bi-weekly procedure (LDL apheresis) to cleanse blood of LDL-C @TheFHFoundation https://t.co/o530LR633r